- Home
- SWBI vs NMRA Comparison
SWBI vs NMRA Comparison
Compare SWBI & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SWBI | NMRA |
|---|---|---|
| Founded | 1852 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 491.2M | 424.4M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | SWBI | NMRA |
|---|---|---|
| Price | $11.65 | $2.14 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $11.00 | $8.00 |
| AVG Volume (30 Days) | 559.1K | ★ 1.2M |
| Earning Date | 03-05-2026 | 03-02-2026 |
| Dividend Yield | ★ 4.45% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $466,396,000.00 | N/A |
| Revenue This Year | $2.62 | N/A |
| Revenue Next Year | $3.23 | N/A |
| P/E Ratio | $55.86 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.73 | $0.61 |
| 52 Week High | $12.05 | $3.25 |
Technical Indicators
Market Signals| Indicator | SWBI | NMRA |
|---|---|---|
| Relative Strength Index (RSI) | 66.57 | 48.79 |
| Support Level | $11.33 | $1.91 |
| Resistance Level | $12.05 | $2.11 |
| Average True Range (ATR) | 0.39 | 0.13 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 70.47 | 45.83 |
Price Performance
Historical ComparisonAbout SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.